// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Angiography-derived functional assessment of non-culprit stenoses with Quantitative Flow Ratio at the time of ST-elevation myocardial infarction

Fernando Macaya - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Myocardial infarction

N/A

Angiography-derived fractional flow reserve in the SYNTAX II trial: diagnostic accuracy of QFR and clinical prognostic value of functional SYNTAX score derived from QFR

Taku Asano - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Correlation between fractional flow reserve and non-invasive myocardial perfusion imaging in patients with severe aortic stenosis and coronary artery disease.

Roberto Scarsini - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Prospective Evaluation of Drug Eluting Self Apposing Stent for the Treatment of Unprotected Left Main Coronary Artery Disease: 1-Year Results of the TRUNC Study

Corrado Tamburino - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left main disease

sirolimus

Impact of the heart team in decision making in patients with severe aortic stenosis – data from the IMPULSE registry

Stefano Salizzoni - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Severe Aortic Stenosis

N/A

Increased specialisation of Chronic Total Occlusion PCI improves success rates but increases procedural complexity: A single centre experience

Maria Mahmood - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic total occlusion

N/A

Pooled analysis of Collateral Channel type and morphology during Retrograde chronic total occlusion Percutaneous Coronary Intervention.

Sudhir Rathore - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic total occlusion

N/A

Transcatheter aortic valve implantation (TAVI) for degenerative surgical bioprosthesis: A single Centre Valve in Valve (ViV) 5 years experience

Mohammad Waleed - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Safety of 2-day discharge following PPCI in STEMI patients

Manish Ramlall - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiogenic shock

N/A

Post-implantation Shear Stress Analysis: An Emerging Tool for Differentiation in Bioresorbable Scaffolds

Erhan Tenekecioglu - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sex Differences and Outcomes Following Rotational Atherectomy: Do Women Receive Optimal Care?

Tom Ford - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Patient-specific computer simulation to optimise transcatheter heart valve sizing and positioning in bicuspid aortic valve morphology

Cameron Dowling - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Bicuspid aortic valve

N/A

Effects of Body Mass Index on the Comparative Effectiveness of PCI Versus CABG for Left Main Coronary Artery Disease: Insights From the EXCEL Trial

Sabato Sorrentino - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Left main disease

Everolimus

In vitro and preclinical evaluation of a thin-strut bioresorbable scaffold: results from bench testing and acute phase study in a non-atherosclerotic porcine model.

Yuki Katagiri - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Quantitative assessment of aortic regurgitation in 7 different types of aortic valves after transcatheter aortic valve implantation: a multicenter analysis by an independent core lab not sponsored by the industry

Patrick Serruys - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic regurgitation

N/A

Comparison of transthoracic echocardiogram with quantitative assessment of aortic regurgitation after TAVI with videodensitometry in a large real-world population: sub-analysis of the RESPOND registry.

Rodrigo Modolo - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic regurgitation

N/A

Feasibility of analysis of a novel quantitative method to assess aortic regurgitation after TAVI: Preliminary results of the ASSESS-REGURGE Protocoled Quantitative ASSESSment of aortic regurgitation using Videodensitometry in a multicenter study in Rotterdam, montrEal, yamaGUchi, segebeRG, amstErdam

Mohamed Abdel-Wahab - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic regurgitation

N/A

Feasibility study of a single synchronized diastolic injection with low contrast volume for aortography in a progressive aortic regurgitation porcine model.

Rodrigo Modolo - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic regurgitation

N/A

Coronary and myocardial haemodynamic effects of Impella LV unloading in patients undergoing high-risk percutaneous coronary intervention

Natalia Briceno - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

Instability of Coronary Flow Velocity and Basal Microvascular Resistance does not Affect Reproducibility of iFR Post- PCI.

Muhammad Aetesam-ur-Rahman - Transcatheter Cardiovascular Therapeutics (TCT) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved